Crossmark

Improvement in residual paravalvular leakage after transcatheter aortic valve replacement with a self-expanding valve: ACURATE neo2 versus ACURATE neo

Crossref DOI link: https://doi.org/10.1007/s12928-025-01170-1

Published Online: 2025-07-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sugiyama, Yoichi

Miyashita, Hirokazu https://orcid.org/0000-0003-1562-9437
Dahlbacka, Sebastian

Vähäsilta, Tommi

Vainikka, Tiina

Jalanko, Mikko

Viikilä, Juho

Laine, Mika

Moriyama, Noriaki
License Information

Text and Data Mining valid from 2025-07-20

Version of Record valid from 2025-07-20
More Information

Article History

Received: 2 February 2025

Accepted: 4 July 2025

First Online: 20 July 2025

Declarations

:

: Y.S. has received honoraria for lectures from Edwards Lifesciences. T.V. is a clinical proctor of Edwards Lifesciences (SAPIEN). M.J. has received honoraria for lectures from Edwards Lifesciences and Medtronic. M.L. reports receiving non-regulatory research grants from Teleflex and consultant fees from Boston Scientific, Edwards Lifesciences, and Medtronic. N.M. has received honoraria for lectures from Abbott, Edwards Lifesciences, and Medtronic. And N.M. is a clinical proctor of Edwards Lifesciences (SAPIEN) and Boston Scientific (ACURATE neo). The other authors have no potential conflicts of interest to declare.

: The study protocol conformed to the principles of the Declaration of Helsinki and was approved by the institutional review board and ethics committee of Helsinki University.

: The authors confirm that patient consent forms have been obtained for this article.

Document is current

Any future updates will be listed below